Saxenda liraglutide injection, solution, DailyMed (2025) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) First generic GLP-1 indicated for weight loss, Teva Pharmaceuticals Investor Relations (2025) Liraglutide injection, solution, DailyMed (2025) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with Type 2 diabetes, Food and Drug Administration (2024) Bioequivalence and interchangeability of generic medications, Merck Manual Consumer Version (2025) Liraglutide injection, DailyMed (2025) Medicare coverage of GLP-1 drugs, Library of Congress (2024) FDA drug shortages, Food and Drug Administration (2025) Compounding when drugs are on FDAs Drug Shortages List, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
If your primary goal is to lose weight in a medically-supervised and effective way, then exploring a treatment plan built around these medications is the logical next step
McDonough V, Stukey J, Cavanagh T (2002) Mutations in erg4 affect the sensitivity of Saccharomyces cerevisiae to medium-chain fatty acids
Insulin resistance correlates with elevated inflammatory markers, and by boosting insulin responsiveness, tirzepatide decreases this inflammatory response
1 Specifically, the increase in obesity and diabetes prevalence in the United States has paralleled the higher burden of CKD observed both nationally and globally
Common side effects The most common effects for metformin are gastrointestinal, says Gidwani
